273 related articles for article (PubMed ID: 26888294)
1. Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis.
van Dongen RM; Zielman R; Noga M; Dekkers OM; Hankemeier T; van den Maagdenberg AM; Terwindt GM; Ferrari MD
Cephalalgia; 2017 Jan; 37(1):49-63. PubMed ID: 26888294
[TBL] [Abstract][Full Text] [Related]
2. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.
Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L
Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721
[TBL] [Abstract][Full Text] [Related]
3. Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen.
Cowan RP; Gross NB; Sweeney MD; Sagare AP; Montagne A; Arakaki X; Fonteh AN; Zlokovic BV; Pogoda JM; Harrington MG
Headache; 2021 Mar; 61(3):536-545. PubMed ID: 33724462
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid phospholipase C activity increases in migraine.
Fonteh AN; Chung R; Sharma TL; Fisher RD; Pogoda JM; Cowan R; Harrington MG
Cephalalgia; 2011 Mar; 31(4):456-62. PubMed ID: 20937607
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal.
Lee MJ; Lee SY; Cho S; Kang ES; Chung CS
J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls.
Kamm K; Straube A; Ruscheweyh R
Cephalalgia; 2019 Oct; 39(12):1535-1543. PubMed ID: 31603037
[TBL] [Abstract][Full Text] [Related]
7. Interictal amylin levels in chronic migraine patients: A case-control study.
Irimia P; Martínez-Valbuena I; Mínguez-Olaondo A; Domínguez-Vivero C; Sánchez-Arias JA; Martínez-Vila E; Luquin MR; Leira R
Cephalalgia; 2021 Apr; 41(5):604-612. PubMed ID: 33269952
[TBL] [Abstract][Full Text] [Related]
8. Cytokines in primary headache disorders: a systematic review and meta-analysis.
Musubire AK; Cheema S; Ray JC; Hutton EJ; Matharu M
J Headache Pain; 2023 Apr; 24(1):36. PubMed ID: 37016284
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptides as a Marker for Chronic Headache.
Riesco N; Cernuda-Morollón E; Pascual J
Curr Pain Headache Rep; 2017 Apr; 21(4):18. PubMed ID: 28281109
[TBL] [Abstract][Full Text] [Related]
10. Clinical study of cerebrospinal fluid neuropeptides in patients with primary trigeminal neuralgia.
Qin ZL; Yang LQ; Li N; Yue JN; Wu BS; Tang YZ; Guo YN; Lai GH; Ni JX
Clin Neurol Neurosurg; 2016 Apr; 143():111-5. PubMed ID: 26918582
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine.
Ramón C; Cernuda-Morollón E; Pascual J
Curr Opin Neurol; 2017 Jun; 30(3):281-286. PubMed ID: 28234796
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally.
Gallai V; Sarchielli P; Floridi A; Franceschini M; Codini M; Glioti G; Trequattrini A; Palumbo R
Cephalalgia; 1995 Oct; 15(5):384-90. PubMed ID: 8536297
[TBL] [Abstract][Full Text] [Related]
13. Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients.
Tuka B; Helyes Z; Markovics A; Bagoly T; Szolcsányi J; Szabó N; Tóth E; Kincses ZT; Vécsei L; Tajti J
Cephalalgia; 2013 Oct; 33(13):1085-95. PubMed ID: 23598374
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers associated with migraine and their potential role in migraine management.
Durham P; Papapetropoulos S
Headache; 2013 Sep; 53(8):1262-77. PubMed ID: 23848170
[TBL] [Abstract][Full Text] [Related]
15. Serological Biomarkers of Chronic Migraine.
Cho S; Chu MK
Curr Pain Headache Rep; 2023 Oct; 27(10):531-542. PubMed ID: 37561314
[TBL] [Abstract][Full Text] [Related]
16. Interictal levels of calcitonin gene related peptide in gingival crevicular fluid of chronic migraine patients.
Fekrazad R; Sardarian A; Azma K; Karami M; Borhani-Haghighi A; Gharesi-Fard B; Movahedi B
Neurol Sci; 2018 Jul; 39(7):1217-1223. PubMed ID: 29654418
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
[TBL] [Abstract][Full Text] [Related]
18. The role of a potential biomarker in patients with migraine: review and new insights.
Ferreira KS; Dhillon H; Velly AM
Expert Rev Neurother; 2021 Jul; 21(7):817-831. PubMed ID: 34210227
[No Abstract] [Full Text] [Related]
19. Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.
Orlovska-Waast S; Köhler-Forsberg O; Brix SW; Nordentoft M; Kondziella D; Krogh J; Benros ME
Mol Psychiatry; 2019 Jun; 24(6):869-887. PubMed ID: 30116031
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid glutamate levels in chronic migraine.
Peres MF; Zukerman E; Senne Soares CA; Alonso EO; Santos BF; Faulhaber MH
Cephalalgia; 2004 Sep; 24(9):735-9. PubMed ID: 15315529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
